Screening Paused

Screening Paused

Cardiovascular risks and elevated lipoprotein

  • Study dedicated to reducing major adverse cardiovascular events in adults with elevated lipoprotein.

    • Age 18 years and above

    • One of the following:

      • Have Lp(a) >175 nmol/L and history of documented ASCVD

      • or LpA > 175 without history of ASCVD but at high risk of ASCVD (e. Hypertension, Type 2 Diabetes, Hyperlipidemia, family history of ASCVD)

    • For those with a history of prior ASCVD event(s), most recent event occurring between > 90 days and 10 years prior to screening.

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

Close-up of a medical monitor displaying vital signs with a focus on blood pressure reading of 130/57 and a waveform on a digital screen.

Screening for this study is paused as of September 14, 2026. You can still send the form below and a coordinator will contact you if screening resumes. This study is run from our Manhattan office (235 East 38th Street).

Think you may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.